Differential diagnosis of hot flashes

Maturitas

Volumn 27, Issue 3, 1997, Pages 203-214

  Mohyi, Darush ^a,b   Tabassi, Khosrow ^c   Simon, James ^d  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Fertility Center of California   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Anxiety; Non menopausal hot flashes; Profuse sweating

Indexed keywords

ADULT; ANXIETY NEUROSIS; ARTICLE; CARCINOID SYNDROME; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; HOT FLUSH; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; PANCREAS ISLET CELL TUMOR; PHEOCHROMOCYTOMA; PREMENOPAUSE; PREVALENCE; SPINAL CORD INJURY; SWEATING; THYROID MEDULLARY CARCINOMA;

EID: 0030795834     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(97)83974-6     Document Type: Article

References (50)

1. Kronenberg F. Hot flashes: epidemiology and physiology. Ann NY Acad Sci 1990;592:52-86.
2. Kronenberg F, Downey J. Thermoregulatory physiology of menopausal hot flashes. Canadian J Physiol Pharmacol 1987;65:1312-22.
3. Brick JF, Crosby TW. Hot flash epilepsy. Southern Med J 1988;81:1-98.
4. Penfield W, Jasper H. Epilepsy and the Functional Anatomy of Human Brain. Little Brown and Co: Boston, 1954, pp 77-88, 105-106, 396-401.
5. Reed WB, Pidgeon J, Becker SW. Patients with spinal cord injury clinical cutaneous studies. Arch Dermatol 1960;83:379-85.
6. Stanworth PA. The significance of hyperhidrosis in patients with post-traumatic syringomyelia. Paraplegia 1982;20:282-7.
7. Burgess TH. The Physiology or Mechanism of Blushing. London: John Churchill, 1839, p 202.
8. Campbell H. Flushing and Morbid Blushing. H.K. Lewis, London: 1890, pp 1-270.
9. Darwin C. The Expression of the Emotions in Man and Animals. Chicago: University Press, 1965, p 372.
10. Freedman RR, Norton D, Woodward S, Cornélissen G. Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995;80:2354-8.
11. 2-Adrenergic mechanism in menopausal hot flushes. Obstet Gynecol 1990;76:573-8.
12. Wilkin JK. Why is flushing limited to a mostly facial cutaneous distribution. J Am Acad Dermatol 1988;19:309-13.
13. Wilkin JK. Flushing reactions. In: Book AJ, Maibach HI (editors) Recent Advances in Dermatology, No. 6., London: Churchill Livingstone, 1983, 157-87.
14. Oates JA, Sjoerdsma A. A unique syndrome associated with secretion of 5HT by metastatic gastric carcinoids. Am J Med 1962;32:333-42.
15. Vetraux J, Salmon RJ, Lanquille O, et al. Carcinoid tumor of common bile duct. Am J Gastroenterol 1981;76:360-2.
16. Engleman K. Personal Observations.
17. Primack A, Wilson J, O'Connor GT, Engelman K, Hull E, Canellos GP. Hepatocellular carcinoma with the carcinoid syndrome. Cancer 1971;27:1182-9.
18. Dockerty MB. Carcinoid tumors. Calif Med 1963;99:1182-9.
19. Hajdu SI, Winnawer SJ, Laird Myers WBP. Carcinoid tumors: a study of 204 cases. Am J Clin Pathol 1974;61:521-8.
20. Martensson H, Nobin A, Sundler F. Carcinoid tumors in the gastrointestinal tract: an analysis of 156 cases. Acta Chir Scand 1960;48:81-8.
21. Torvik A. Carcinoid syndrome in a primary tumor of the ovary. Acta Pathol 1960;48:81-8.
22. Melmon KL, Sjoerdsma A, Mason DT. Distinctive clinical and therapeutic aspects of the syndrome associated with bronchial carcinoid tumors. Am J Med 1965;39:568-81.
23. Farrior III JB, Hyams VJ, Benke RH, Farrior JB. Carcinoid apudoma arising in a glomus jugular tumor. Laryngoscope 1980;90:110-9.
24. Kaplan EL, Sizemore GW, Peskin GW, Jaffe BM. Humoral similarity of carcinoid tumors and medullary carcinoma of the thyroid. Surgery 1973;74:21-9.
25. Matsuyama M, Inoue T, Ariyoshi Y, Doi M, Suchi T, Sto T, Tashiro K. Argyrophil cell carcinoma of the uterine cervix with ectopic production of ACTH B-MSH, serotonin, histamine, and amylase. Cancer 1979;44:1813-23.
26. Engelman, K. Malignant carcinoid syndrome. In: DeG-root LJ, editor. Textbook of Endocrinology, 3rd edition , vol. 3. Philadelphia: Saunders, 1995: 2649-57.
27. Adamson AR, Peart WS, Graham-Smith DG, Starr M. Pharmacological blockage of carcinoid flushing provoked by catecholamines and alcohol. Lancet 1969; 2: 595.
28. Frolich JC, Bloomgarden ZT, Oates JA, McGuigan JE, Rabinowitz D. The carcinoid flush provocation by pentagastrin and inhibition by somatostatin. N Engl J Med 1978;299:1055-7.
29. Braunwald E, Isselbacher KJ. In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK, editors. Harrison's Principles of Internal Medicine, 12th ed, New York, McGraw-Hill, 1991.
30. Oates JA, Butler TC. Pharmacologic and endocrine aspects of carcinoid syndrome. Adv Pharmacol 1967;5:109-28.
31. 2 in patients with mastocytosis. N Eng J Med 1980;303:1400-4.
32. Demis DJ. The mastocytosis syndrome: clinical and biological studies. Ann Intern Med 1963;59:194-206.
33. Webb TA. Li Chin, Yam Lung. T. Systemic mast cell disease. Cancer 1982;49:927-38.
34. Parker CW, Cryer PG. Kissane, J.M. Systemic mastocytosis. Am J Med 1976;61:671-80.
35. Wyngaarden JB, Smith LH Jr, editors. Cecil Textbook of Medicine, 18th ed. Philadelphia: Saunders, 1988
36. Bravo EL, Gifford RW Jr. Pheochromocytoma: diagnosis, localization, and management. N Eng J Med 1984;311:1298-303.
37. Engelman K. Pheochromocytoma. Clin Endocrinol Metab 1977;6:769-97.
38. Hamilton BP, Landsberg L, Levine RJ. Measurement of urinary epinephrine in screening for pheochromocytoma in men. Am J Med 1978;65:1027-32.
39. Duncan MW, Compton P, Lazarus L, Smythe GA. Measurement of norepinephrine and 3,4-dihydroxyphenylglycol in urine and plasma for the diagnosis of pheochromocytoma. N Engl J Med 1988;319:136-42.
40. Ross EJ, Prichard BN, Kaufman L, Robertson AI, Harries BJ. Preoperative and operative management of patients with pheochromocytoma. Br Med J 1971;1:191-8.
41. Laursen K, Damgaard-Pederson K. CT for pheochromocytoma diagnosis. Am J Roentgenol 1980;134:277-80.
42. Sizemore GW, Carney JA, Heath H. III. Epidemiology of medullary carcinoma of the thyroid gland. Surg Clin North Am 1977;57:633-45.
43. Krejs GJ. Vipoma syndrome. Am J Med 1981;82 suppl 5B:37-48.
44. Cronin RE, Kaehny WD, Miller PD, Stables DP, Gabow PA, Ostroy PR, Schrier R. Renal cell carcinoma: unusual systemic manifestations. Medicine 1976;55:291-311.
45. Cronan J, Zeman RK. Renal mass imaging. The internist's role. Am J Med 1986;81:1026-32.
46. Brodsky G, Garnick MG. Renal tumors in the adult patient. In: Renal Pathology. CC Tisher, BM Brenner (eds), Philadelphia, Lippincott, 1989, p 1467.
47. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., rev. American Psychiatric Press, Washington, 1987, p. 567.
48. Wilkin JK. Effect of nadolol on flushing reactions in rosacea. J Am Acad Dermatol 1989;20:202-5.
49. Sato K, Kang WH, Saga K, Saga K, Sato KI. Biology of sweat glands and their disorders. II. Disorders of sweat gland function. J Am Acad Dermatol 1989;20:713-26.
50. Rowland LP. Nervous System Diseases. In: Textbook of Neurology, 8th ed. Philadelphia: Lea and Febiger, 1989, p 964.